Search

everythinglearnresearchcommunity

for

Search:↓

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Testosterone helps human pancreatic cells increase insulin release.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Three siblings with a rare genetic condition had abnormal sexual development and chose different gender identities, needing surgery and therapy.

Plant extracts like Avicennia marina, Boehmeria nipononivea, and Camellia sinensis could potentially treat hair loss with fewer side effects than synthetic drugs.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

Finasteride reduces scalp DHT levels, potentially treating male pattern baldness.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Scientists created cell lines from balding patients and found that cells from the front of the scalp are more affected by hormones that cause hair loss than those from the back.

Finasteride affects the male rat brain by reducing certain protein activation, but these effects may reverse after stopping the drug.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Testosterone's muscle-building effects do not require its conversion to DHT.

Accurate protein modeling can help develop new treatments for prostate cancer and other diseases.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

A microemulsion with Carthamus tinctorius extract effectively inhibits 5α-reductase and improves skin and hair follicle delivery.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Finasteride helps treat hair loss by blocking enzyme activity.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

Thujae occidentalis semen extract may help treat male pattern baldness by blocking a hair loss-related enzyme and reducing hair loss in mice.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.